Health knowledge made personal
WellPage for Contrast Agents
+ Bookmark › Share
Go
Search posts:

Contrast Agents - Articles

FDA Drug Safety Communication: New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction by FDA Posted Thu 09 Sep 2010 9:56am Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Approved Gadolinium Based Contrast Agents Safety Announcement [09-09-2010] The U.S. Food and Drug Administration (FDA) is requiring changes in the drug label for gadolinium-ba ... Read on »
Researchers Develop Groundbreaking New Graphene-Based MRI Contrast Agent by Ed H. Doctor of Pharmacy Posted Thu 07 Jun 2012 9:52pm Dr. Balaji Sitharaman, PhD, an Assistant Professor in the Department of Biomedical Engineering at Stony Brook University, and a team of researchers developed a new, highly efficacious, potentially safer and more cost effective nanoparticle-based MRI (magnetic resonance imaging) contrast agent for improved disease diagnosis and detection. The mo ... Read on »
Superior Method of Preparing Dendrimers for Use as Magnetic Resonance Imaging (MRI) Contrast Agents by nih.gov Posted Mon 10 Aug 2009 5:00pm Description of Invention: There is a need to develop more efficient gadolinium-containing (Gd) contrast agents for magnetic resonance imaging (MRI) as the small molecules presently used clinically have the disadvantage of being rapidly cleared from circulation and excreted by the kidneys. Dendrimer-based macromolecular MR ... Read on »
Microfabricated Particles Useful as MRI Contrast Agents by nih.gov Posted Sun 14 Mar 2010 5:00pm Description of Invention: MRI contrast agents are versatile yet lack the sensitivity and multiplexing capabilities of optical agents. Available for licensing is an invention pertaining to microfabricated structures that can be used as MRI contrast agents with enhanced functionality or as micro-RFID (radio-frequency identifica ... Read on »
Gadolinium-based Contrast Agents: Class Labeling Change - Risk of Nephrogenic Systemic Fibrosis by FDA Posted Thu 09 Sep 2010 1:50pm Ablavar (gadofosveset trisodium), Eovist (gadoxetate disodium), Magnevist (gadopentetate dimeglumine), Multihance (gadobenate dimeglumine), Omniscan (gadodiamide), Optimark (gadoversetamide injection), Prohance (gadoteridol) [Posted 09/09/2010] AUDIENCE: Radiology, Nephrology, Dermatology ISSUE: FDA is requirin ... Read on »
Superparamagnetic Nanocomplexes and Their Use as Contrast Agents in MRI by nih.gov Posted Mon 28 Mar 2011 8:00pm Description of Invention: The invention offered for licensing and commercial development relates to the fields of cell therapy and tracking of such therapy by magnetic resonance imaging. More specifically the technology describes novel superparamagnetic magnetic resonance contrast agents, methods of making the agents, and meth ... Read on »
MRI contrast agents change stem cell proliferation by David Granovsky Posted Mon 14 Feb 2011 1:19pm MRI contrast agents change stem cell proliferation Tampa, Fla. (Nov. 01, 2010) – When researchers tested three different labeling agents on three different stem cell populations to determine what effect the labeling agents had on stem cell phenotype, biological behavior and migration abilities, they found changes in stem cell proliferation depend ... Read on »
Important update on the MRI contrast agent gadolinium… by Margaret Patient Expert Posted Mon 24 Jan 2011 5:41am Do you remember my post on gadolinium? If not, here it is: http://margaret.healthblogs.org/2009/12/13/the-gadolinium-used-in-mris-makes-myeloma-cells-proliferate/  (there is also a corresponding Page, which you can find by scrolling down my Page section on the right). Well, today, thanks to a blog reader (see previous post, comme ... Read on »